ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026
Repurposing biosimilars, rethinking costs: a framework for sustainable drug pricing for repurposed bevacizumab for intravitreal injections.
Evert A Manders et al.PubMed ↗Publisher ↗
No numbers read from the abstract.